Schizophrenia - P & P

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/217

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 5:07 PM on 10/10/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

218 Terms

1
New cards

Describe the main characteristics of schizophrenia.

Schizophrenia is characterized by symptoms such as delusions, hallucinations, disorganized speech, negative symptoms, and social or occupational dysfunction.

2
New cards

Explain the diagnosis criteria for schizophrenia according to DSM and ICD.

Both DSM and ICD require two or more characteristic symptoms to be present for a significant portion of time during a 1-month period, with continuous signs persisting for at least 6 months (DSM) or 1 month (ICD).

3
New cards

Define psychosis and its relation to schizophrenia.

Psychosis is a severe mental illness where delusions and hallucinations are prominent, and schizophrenia is one of the main psychotic disorders.

4
New cards

How do the DSM and ICD differ in their approach to diagnosing schizophrenia?

The ICD-11 has a shorter duration requirement for symptoms and considers at least one of the core symptoms mandatory, which may lead to earlier treatment initiation.

5
New cards

Explain the significance of negative symptoms in schizophrenia diagnosis.

Negative symptoms include diminished emotional expression, avolition, and alogia, and are crucial for diagnosis as they reflect the functional impairment of the individual.

6
New cards

Describe the Positive and Negative Syndrome Scale (PANSS) used in assessing schizophrenia.

PANSS measures the prevalence of positive and negative symptoms in schizophrenia, consisting of 7 items for positive symptoms, 7 for negative symptoms, and 16 for general psychopathology.

7
New cards

What are the potential new antipsychotics being researched?

Potential new antipsychotics may have no dopaminergic profile, aiming to reduce side effects associated with traditional antipsychotic medications.

8
New cards

Explain the role of animal models in schizophrenia research.

Animal models are used to study the biological and structural brain abnormalities associated with schizophrenia, helping to understand the disorder's mechanisms.

9
New cards

Describe the main side effects of antipsychotic treatments.

Common side effects of antipsychotic treatments can include weight gain, sedation, and extrapyramidal symptoms, which can impact patient adherence to treatment.

10
New cards

Define schizoaffective disorder and its symptoms.

Schizoaffective disorder is characterized by a combination of psychotic symptoms and mood symptoms, which may include hallucinations, delusions, and mood disturbances.

11
New cards

How does the experience of influence manifest in schizophrenia?

Patients may feel that their thoughts, actions, or emotions are controlled by an outside force, leading to experiences such as thought withdrawal or thought broadcasting.

12
New cards

What is the significance of the duration of symptoms in schizophrenia diagnosis?

The duration of symptoms is critical for diagnosis, as it helps differentiate schizophrenia from other conditions and ensures that symptoms are not due to substance use or another medical condition.

13
New cards

Explain the concept of social/occupational dysfunction in the context of schizophrenia.

Social/occupational dysfunction refers to a marked decline in work, interpersonal relations, or self-care compared to the level achieved prior to the onset of symptoms.

14
New cards

Describe the symptoms included in the assessment of general psychopathology in PANSS.

General psychopathology in PANSS includes symptoms such as depression, anxiety, motor retardation, and mannerisms, which are assessed alongside positive and negative symptoms.

15
New cards

What are the implications of having psychotic components in other psychiatric conditions?

Conditions like severe unipolar depression and bipolar disorders may exhibit psychotic features, complicating diagnosis and treatment strategies.

16
New cards

Describe the general population prevalence of schizophrenia and related disorders.

Schizophrenia and related disorders have a prevalence of less than 1.5% in the general population.

17
New cards

Explain the living situations of individuals with schizophrenia.

Many individuals with schizophrenia are unable to work, live with relatives or family, reside in social institutions, or live in specialized institutions, with few living independently.

18
New cards

Define the employment status of individuals with schizophrenia.

Less than 13% of individuals with schizophrenia have a permanent job.

19
New cards

Discuss the common misconceptions about schizophrenia.

Schizophrenia does not cause violence, and individuals with schizophrenia do not have split personalities.

20
New cards

How do individuals with schizophrenia typically harm themselves?

Individuals with schizophrenia often harm themselves rather than others, with self-harming behaviors, such as mutilation, being very common.

21
New cards

Explain the average life expectancy of individuals with schizophrenia compared to the general population.

Individuals with schizophrenia typically die 10 to 20 years earlier than the general population, sometimes due to treatment-related factors.

22
New cards

What is the suicide rate among individuals with schizophrenia?

The suicide rate among individuals with schizophrenia is extremely high, at around 10%.

23
New cards

Describe the prevalence of psychotic disorders among homeless individuals.

Recent studies show that 21% of homeless individuals have psychotic disorders, with 12% specifically diagnosed with schizophrenia.

24
New cards

Discuss the mental health status of men and women in the UK prison system.

Around 15% of men and 25% of women in the UK prison system suffer from serious mental illnesses, including psychotic disorders.

25
New cards

Explain the changes in the Mental Health Service in the UK since 2000.

The Mental Health Service in the UK has lost approximately a quarter of its in-patient beds since 2000.

26
New cards

What is the effectiveness of antipsychotic medications for treating schizophrenia?

Antipsychotics are the only effective treatment for schizophrenia, with an 80% response rate, but they take 3-4 weeks to work.

27
New cards

Discuss the limitations of antipsychotic medications.

Antipsychotics have little effect on negative and cognitive symptoms, can have strong side effects, and previous treatments before antipsychotics were largely ineffective.

28
New cards

Describe the typical onset age for schizophrenia.

Schizophrenia generally has an early onset, typically between ages 17-20 for males and 20-25 for females.

29
New cards

Explain the differences in symptoms between early and late onset schizophrenia.

Late onset schizophrenia tends to have fewer negative symptoms, better neuropsychological performance, and a better response to antipsychotics, with a higher prevalence in females.

30
New cards

What are the main symptoms that can appear in individuals with schizophrenia?

Main symptoms include marked isolation, suspiciousness, irritability, odd beliefs, perceptual aberrations, and poor hygiene, among others.

31
New cards

Discuss the concept of the prodromal phase in schizophrenia.

The prodromal phase is characterized by a heterogeneous group of behaviors that may continue for weeks to years without prominent psychotic symptoms.

32
New cards

How does early treatment of the first episode of schizophrenia affect long-term outcomes?

The quicker the first episode is treated with antipsychotics, the better the long-term outcome tends to be.

33
New cards

What happens to patients who stop taking their antipsychotic medication?

75% of patients who stop taking their antipsychotic medication experience significant worsening of symptoms over the course of a year.

34
New cards

Explain the concept of treatment holidays in schizophrenia management.

Treatment holidays, or intermittent interruption of treatment when a patient is stabilized, are generally not recommended due to the risk of worsening symptoms.

35
New cards

Describe the consequences of discontinuing treatment for schizophrenia.

Discontinuing treatment may lead to exacerbation of symptoms, undermining therapeutic progress.

36
New cards

Explain the impact of untreated first episodes of schizophrenia.

Symptoms get worse if the first episode is not treated.

37
New cards

How can behavioral therapies assist patients with schizophrenia?

Behavioral therapies can help patients learn to cope better with their voices and hallucinations, reduce fear, and improve quality of life.

38
New cards

Define cognitive remediation therapy in the context of schizophrenia treatment.

Cognitive remediation therapy aims to promote thinking skills and may lead to modest but significant improvement in negative symptoms.

39
New cards

What is the genetic risk of developing schizophrenia if a parent is affected?

If one of my parents suffers from schizophrenia, my chance to develop the disease is approximately 10%.

40
New cards

How does having a homozygote twin with schizophrenia affect one's risk of developing the disorder?

If my homozygote twin brother or sister has the disease, my chance to develop schizophrenia is around 30-50%.

41
New cards

What is the risk of developing schizophrenia if one has a sibling with the disorder?

If one of my siblings has the disease, my chance to develop schizophrenia is about 8%.

42
New cards

Explain the genetic overlap between schizophrenia and other psychiatric disorders.

There is important genetic overlap with bipolar disorders and autism, with shared clinical characteristics and polygenic common variants.

43
New cards

Describe the common clinical characteristics between Bipolar 1 and Schizophrenia patients.

Both have a peak onset in early adulthood, a prevalence around 1%, presence of psychotic symptoms, and increased suicide risk.

44
New cards

How do environmental factors contribute to the risk of developing schizophrenia?

Environmental factors, such as antenatal problems, perinatal issues, drug abuse, and social adversity, can increase vulnerability, especially in combination with genetic susceptibility.

45
New cards

What role does cannabis play in the onset of schizophrenia?

Cannabis can trigger the onset of schizophrenia in predisposed individuals, but its role in those not previously vulnerable is disputable.

46
New cards

Explain the relationship between urbanicity and schizophrenia risk.

Risk of schizophrenia is increased among individuals living in densely populated areas and those who change residence during childhood and adolescence.

47
New cards

What structural changes are observed in the brains of individuals with schizophrenia?

Higher third ventricle size, lower cerebrum size, and volume reduction of the frontal lobe gray matter are observed.

48
New cards

How does antipsychotic treatment affect cortical thickness in schizophrenia patients?

Antipsychotic treatment has strong effects on cortical thickness, with the biggest differences observed with first-generation antipsychotics.

49
New cards

What neurochemical abnormalities are associated with schizophrenia?

Abnormalities of dopaminergic function are evident, as increasing dopamine function can mimic or exacerbate positive symptoms of schizophrenia.

50
New cards

How do antipsychotics work in relation to dopamine receptors?

Antipsychotics have an affinity for dopamine D2 receptors, which is common among them.

51
New cards

What effect does amphetamine have on dopamine function in relation to schizophrenia?

Amphetamine increases dopamine function and can cause schizophrenia-like positive symptoms in controls, while exacerbating symptoms in patients.

52
New cards

Describe the relationship between dopamine receptors and schizophrenia based on post-mortem studies.

Some post-mortem studies have shown a greater density of dopamine receptors in the brains of schizophrenia patients, although this finding is disputed.

53
New cards

Explain the significance of the dopamine D1/D2 receptor ratio in schizophrenia.

Imaging studies have shown an abnormal dopamine D1/D2 receptor ratio, which may disrupt information processing, particularly with high D1 density in cortical areas.

54
New cards

How do 5-HT2A receptor agonists relate to psychotic symptoms?

Agonists of 5-HT2A receptors, such as psilocybin and LSD, are psychotomimetics that can provoke mental effects like mystical states, synesthesia, and schizophrenia-like symptoms, including hallucinations.

55
New cards

Define the role of antipsychotics in relation to 5-HT2A receptors.

Most antipsychotics, especially second-generation antipsychotics, block 5-HT2A receptors, although some effective antipsychotics do not target these receptors.

56
New cards

Explain the impact of NMDA receptor abnormalities on schizophrenia.

Abnormalities in NMDA receptor function, particularly hypofunction, are associated with cognitive processes and may lead to reductions in grey matter volume seen in schizophrenia.

57
New cards

Describe the effects of non-competitive NMDA antagonists on schizophrenia symptoms.

Non-competitive NMDA antagonists like PCP and ketamine can induce schizophrenia-like behaviors, exacerbating positive symptoms and causing cognitive impairment.

58
New cards

How does glycine function in NMDA receptor activation?

NMDA receptor activation requires glycine or D-serine to bind as a co-agonist, alongside glutamate.

59
New cards

What are the psychotomimetic effects of ketamine and PCP?

Ketamine and PCP are non-competitive NMDA antagonists that can mimic both positive and negative symptoms of schizophrenia.

60
New cards

Discuss the potential role of the cholinergic system in schizophrenia.

High doses of scopolamine can produce strong psychotomimetic effects, including hallucinations and agitation, indicating a role for the cholinergic system in schizophrenia.

61
New cards

What is the significance of histamine H3 antagonists in treating schizophrenia?

Histamine H3 antagonists may be beneficial in treating cognitive symptoms associated with schizophrenia.

62
New cards

Explain the concept of multiple neurotransmitter system dysfunction in schizophrenia.

Schizophrenia likely involves dysfunction across multiple neurotransmitter systems, suggesting that treatments targeting only one pathway may not adequately address the disorder's complexity.

63
New cards

Describe the implications of serotonin and dopamine innervations in the brain.

Serotonin innervations are widespread and overlap with dopamine, which has two main nuclei: the VTA/SNC, affecting motivation and pleasure, and the nigrostriatal pathway, controlling movements.

64
New cards

What evidence suggests hyperactivity in the mesolimbic dopamine pathway in schizophrenia?

There is evidence suggesting that the mesolimbic dopamine pathway is hyperactive, while the mesocortical dopamine pathway is underactive in schizophrenia.

65
New cards

Discuss the potential autoimmune components in schizophrenia.

There may be autoimmune components causing mild inflammation that impair the blood-brain barrier, making it more permeable to inflammatory agents, although this is not fully proven.

66
New cards

What is the significance of NMDA receptor antibodies in a subgroup of schizophrenia patients?

A small subgroup of schizophrenia patients (2-5%) resistant to antipsychotics may develop antibodies against NMDA receptors, which can be treated with selective plasma filtration.

67
New cards

Describe the role of microglia in schizophrenia.

Microglia may exhibit abnormalities that lead to excessive synaptic pruning, which is thought to contribute to the symptoms of schizophrenia.

68
New cards

Explain the significance of animal models in antipsychotic drug testing.

Animal models are used to test potential antipsychotic effects of drugs, but no model effectively encapsulates all symptoms of schizophrenia.

69
New cards

How does chronic neonatal administration of PCP affect cognitive function in animals?

Chronic neonatal administration of PCP induces lasting cognitive deficits and increases in positive symptom equivalents in animal models.

70
New cards

What is the effect of D-amphetamine in animal models?

D-amphetamine induces excessive motor activity and preferentially activates dopamine D2 receptors in limbic pathways, often considered a model of mania.

71
New cards

Define the role of GABA chandelier neurons in brain abnormalities related to schizophrenia.

There is a hypothesis suggesting that GABA chandelier neurons in prefrontal areas may be involved in the neuronal abnormalities associated with schizophrenia.

72
New cards

Describe the discovery and significance of chlorpromazine.

Chlorpromazine, discovered in 1951, was the first antipsychotic drug, initially used as a tranquilizer and compared in impact to penicillin for infectious diseases.

73
New cards

What are some examples of first-generation antipsychotics that followed chlorpromazine?

Examples include Haloperidol, trifluoperazine, fluphenazine, and flupentixol.

74
New cards

Explain the impact of chlorpromazine on psychiatric hospital populations.

The introduction of chlorpromazine significantly reduced the number of patients in psychiatric hospitals, similar to the impact of penicillin on infectious diseases.

75
New cards

Describe the discovery and development timeline of clozapine.

Clozapine was discovered in 1956, marketed in 1972, withdrawn in 1976 due to granulocytosis, and reintroduced in 1988 as an effective treatment for schizophrenia.

76
New cards

What are the risks associated with clozapine treatment?

Clozapine carries a risk of agranulocytosis (1-3%), particularly during the first year of treatment, requiring frequent monitoring.

77
New cards

How do first-generation antipsychotics generally interact with dopamine receptors?

First-generation antipsychotics have a very high affinity for D2/D3 receptors, which increases the likelihood of motor side effects.

78
New cards

What is the general receptor affinity profile of second-generation antipsychotics?

Second-generation antipsychotics have moderate affinity for D2/D3 receptors, high affinity for serotonin 5-HT2A, and variable effects on other receptors.

79
New cards

Explain the advantages of second-generation antipsychotics over first-generation ones.

Second-generation antipsychotics are generally preferred for treating negative symptoms due to lower incidence of movement side effects compared to first-generation drugs.

80
New cards

Describe the potential effects of second-generation antipsychotics on cognitive and negative symptoms.

Some second-generation antipsychotics with partial agonist effects on 5-HT1A and antagonistic effects on 5-HT7 may have better efficacy on cognitive and negative symptoms.

81
New cards

What is the significance of the term 'third generation antipsychotics'?

Third generation antipsychotics may offer advantages over clozapine, particularly in terms of reduced metabolic effects.

82
New cards

Describe the affinity of a drug for a receptor.

Affinity refers to the concentration of a drug necessary to occupy half of all the receptors present. A higher affinity means a lower concentration is needed for the drug to be effective.

83
New cards

Explain the significance of pKi values in pharmacology.

pKi values indicate the concentration of a drug needed to displace half of a selective ligand from a receptor. A pKi between 9-12 indicates very high affinity, while a pKi below 6 suggests very low affinity.

84
New cards

Define the main side effects caused by neuroleptics due to dopamine D2/3 blockade.

Main side effects include extra-pyramidal symptoms such as tardive dyskinesia, acute dystonia, akathisia, and parkinsonism, as well as hyperprolactinemia, sexual dysfunction, and rare conditions like neuroleptic malignant syndrome.

85
New cards

How does clozapine differ from other antipsychotics in terms of receptor affinity?

Clozapine has a relatively low affinity for D2 receptors but a high affinity for 5HT2A and other receptors, which contributes to its unique efficacy and side effect profile.

86
New cards

Do second generation antipsychotics (SGA) have a higher efficiency than first generation antipsychotics (FGA) for positive symptoms?

There is no clear evidence that SGAs are more efficient than FGAs in treating positive symptoms, except for clozapine, which is used for treatment-resistant cases.

87
New cards

Explain the monitoring requirements for clozapine treatment.

Clozapine requires monitoring of full blood counts weekly for the first 18 weeks, then fortnightly for one year, and monthly thereafter due to the risk of agranulocytosis.

88
New cards

Describe the Glasgow Antipsychotic Side-Effect Scale (GASS).

The GASS is a 22-item self-administered questionnaire used to assess the severity of side effects from antipsychotic medications, covering various symptoms including sedation, cardiovascular issues, and metabolic changes.

89
New cards

What are the potential risks associated with all antipsychotic medications?

All antipsychotic medications can cause ventricular arrhythmias, increase the risk of sudden cardiac death, sedation, sexual dysfunction, postural hypotension, and metabolic problems like weight gain.

90
New cards

How should the dose of clozapine be adjusted if a dose is forgotten?

If a dose of clozapine is forgotten, the dose should be increased very progressively, starting from 12.5 mg to the target range of 300-450 mg, and can go up to 900 mg.

91
New cards

Explain the relationship between pKi values and drug potency.

The lower the concentration needed to achieve a therapeutic effect, the higher the affinity and potency of the drug. A pKi value of 9 indicates high potency, while a pKi below 6 suggests low potency.

92
New cards

What are the common motor side effects associated with neuroleptics?

Common motor side effects include tardive dyskinesia, acute dystonia, akathisia, and parkinsonism, primarily due to D2 blockade in motor areas.

93
New cards

Describe the prescribing criteria for clozapine.

Clozapine can be prescribed only if the patient has not responded to two antipsychotic medications, one of which must be a second-generation antipsychotic, administered at appropriate doses and duration.

94
New cards

What is the risk of agranulocytosis associated with clozapine?

Clozapine carries a small risk of agranulocytosis, approximately 1.5%, necessitating regular blood monitoring.

95
New cards

How do second generation antipsychotics affect metabolic health compared to first generation antipsychotics?

Second generation antipsychotics are associated with more significant metabolic effects, such as weight gain, compared to first generation antipsychotics.

96
New cards

Explain the concept of extra-pyramidal side effects.

Extra-pyramidal side effects are movement disorders caused by the blockade of dopamine D2 receptors, leading to symptoms like tardive dyskinesia and parkinsonism.

97
New cards

Describe involuntary movements associated with antipsychotic use.

Involuntary movements include jerky writhing movements of the face and body, chewing, sticking the tongue out, lip smacking, and waving the arms. These movements can cause distress, disfigurement, embarrassment, and dysfunction.

98
New cards

Explain the potential long-term effects of antipsychotic treatment on involuntary movements.

Involuntary movements may persist long after the cessation of drugs, and in some cases, they can be permanent.

99
New cards

Define the cause of hypersensitization in relation to antipsychotic medication.

Chronic blockade of dopamine receptors leads to hypersensitization when the receptors become unoccupied.

100
New cards

How can dosage adjustments affect symptoms of involuntary movements?

Reducing doses can temporarily exacerbate symptoms, while increasing doses can temporarily improve them.